27 03, 2025

EVscale™ and TAmiRNA at ISEV Vienna, April 24-27, 2025

2025-03-27T10:53:51+01:00March 27th, 2025|biomarker, biomarkers, Evercyte, EVscale, extracellular vesicle, microRNAs, Personalized medicine, smallRNA|Comments Off on EVscale™ and TAmiRNA at ISEV Vienna, April 24-27, 2025

We are thrilled to announce that TAmiRNA, Evercyte, and Phoenestra have united to form EVscale™, a powerful collaboration dedicated to providing comprehensive solutions for extracellular vesicle (EV) research, diagnostic, and therapeutic development. We will be exhibiting at the prestigious ISEV (International Society for Extracellular Vesicles) Conference in Vienna from April 24-27, 2025, and we invite you to visit us at Booth B13. The EV Scale platform is designed to streamline every step of your EV workflow, catering to both therapeutic development and sophisticated omics-based biomarker discovery. Leveraging the unique expertise of each partner, we offer an integrated approach that encompasses: Optimized EV Production for Therapeutics: Utilizing a range of high-quality mesenchymal stromal cell (MSC) lines from Evercyte, [...]

17 01, 2023

Biogenity Joins Forces with TAmiRNA

2023-03-10T08:29:26+01:00January 17th, 2023|biomarkers, diagnose disease, microRNA, NGS, smallRNA, treatment monitoring|Comments Off on Biogenity Joins Forces with TAmiRNA

The collaboration between Biogenity and TAmiRNA is a big step towards further enabling our clients to identify new biomarkers that can be used to diagnose disease, monitor treatment response, and predict patient outcomes. And an important step to advance omics research and bring better healthcare to future generations. click here to read the press release

Go to Top